Skip to main content

BRIEF RESEARCH REPORT article

Front. Surg., 13 June 2024
Sec. Orthopedic Surgery

Analysis of surgical treatment of cervical spondylotic amyotrophy

\r\nZhong Yu,&#x;Zhong Yu1,†Haofuzi Zhang,&#x;Haofuzi Zhang2,†Yanjun Wang
\r\nYanjun Wang1*
  • 1Department of Emergency, Honghui Hospital, Xi'an Jiaotong Uinversity, Xi'an, China
  • 2Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi’an, China

Background: Cervical spondylotic amyotrophy (CSA) is a special type of cervical spondylosis based on cervical degeneration, which is mainly manifested by weakness and atrophy of upper limb muscles without obvious sensory impairment. Various diagnostic and treatment strategies used; however, discrepancies exist. We tried to discuss diagnosing and treating CSA.

Methods: 15 patients with CSA were diagnosed in the Orthopedics Department of the First Affiliated Hospital of Zhengzhou University, aged 42–70 years old. The duration of preoperative symptoms of amyotrophy was 6 to 240 months. 12 patients received surgical treatment, and 3 patients received conservative treatment. The patients were divided into two groups according to the site of preoperative amyotrophy. The manual muscle test was used to evaluate the patients' muscle strength pre-and postoperatively.

Results: During postoperative follow-up, the muscle strength of 12 patients improved to different degrees compared to before surgery. The improvement effect was excellent in 2 cases, good in 6, and moderate in 4. There was no decrease in postoperative muscle strength compared with that before surgery. The satisfaction rate of the effect was 66.7%. The two groups had no statistically significant difference in preoperative muscle strength. The postoperative muscle strength of the proximal group was significantly better than that of the distal group.

Conclusion: The surgical effect of CSA of the proximal type is significantly better than that of the distal type. The recovery effect of amyotrophy after surgery for distal type CSA is poor; thus, surgical treatment should be carefully considered.

1 Introduction

Cervical spondylotic amyotrophy (CSA) is a special type of cervical spondylosis based on cervical degeneration, which is mainly manifested by weakness and atrophy of upper limb muscles without obvious sensory impairment (1). In 1965, Keegan (2) first proposed this concept in an anatomical case report. According to the location of amyotrophy, it can be divided into two subtypes: proximal type (such as scapular muscle, deltoid muscle, biceps brachii) and distal type (such as triceps brachii, forearm muscle and intrinsic hand muscle) (3). The incidence rate of the disease is low, easy to misdiagnosis. At present, there are disputes about the choice of treatment methods and timing of CSA. Inui et al. believe that CSA can achieve good curative effect through conservative treatment (4). Taychi et al. suggested that those who failed conservative treatment should undergo surgical treatment (5). However, some scholars believe that CSA needs timely surgical treatment (2, 6). This study reviewed the diagnosis and treatment of 15 patients with CSA, and analyzed their clinical characteristics, diagnosis, treatment methods and efficacy.

2 Materials and methods

2.1 Inclusion and exclusion criteria

Inclusion criteria: Upper limb amyotrophy; No obvious sensory disturbance; Complete preoperative imaging examination [including cervical x-ray, computed tomography (CT), magnetic resonance imaging (MRI), and electromyogram (EMG)]; Complete regular outpatient follow-up.

Exclusion criteria: Motor neuron disease; Hirayama disease; Amyotrophic lateral sclerosis; Shoulder sleeve injury; Lost to follow-up.

2.2 General information

From March 2021 to June 2022, 15 patients were admitted to the Department of Orthopedics of the First Affiliated Hospital of Zhengzhou University and diagnosed with CSA, including 7 males and 8 females, aged from 42 to 70 years (average 55.1 years). The duration of preoperative amyotrophy symptoms was 6 to 240 months (average 63.6 months). The patients were divided into two groups according to the site of preoperative amyotrophy: Proximal type group, 6 cases in total; Distal type group, 6 cases in total; Another 3 cases were treated conservatively. There was no statistical significance between the two groups in age, course of the disease, and follow-up time after surgery, as shown in Table 1.

Table 1
www.frontiersin.org

Table 1. Comparison of baseline data between two groups of patients.

2.3 Surgical methods

When patients receive conservative treatment for at least one month which is ineffective in the end, the patients shall be treated with anterior cervical decompression and fusion or posterior cervical laminoplasty according to the compression position of the lesion, the number of the lesion segments, the curvature of the cervical spine. The principle is to relieve the compression of nerve root and spinal cord and reconstruct the physiological curvature of cervical spine.

2.4 Follow up and efficacy evaluation

All patients were followed up at postoperative 3, 6, and 12 months and every year after that. The follow-up aimed to evaluate the recovery of muscle strength compared with before surgery, the improvement of amyotrophy after surgery, and conduct imaging review.

2.5 Determination of muscle strength level

The muscle strength level is divided into 6 levels: 0, 1, 2, 3, 4, and 5. The muscle strength level of 5 is normal. The muscle strength of patients before and during the follow-up was evaluated by Manual Muscle Testing (MMT), which is based on the function of the subject's muscles or muscle groups, placing the patient in different examination positions, instructing the patient to perform certain movements in a state of anti-gravity, or resistance, and achieving the maximum range of motion, which then were divided into four groups (“excellent”, “good”, “moderate”, and “bad”). It is “excellent” that the muscle strength improve by ≥2 grades than that before operation or to restore the muscle strength to the normal level after operation. The muscle strength at follow-up was better than that before operation; It is “good” that the muscle strength improve by >1 grades than that before operation; It is “moderate” that the muscle strength has no obvious improvement compared with that before operation; It is “bad” that the muscle strength decrease compared with preoperative. At the follow-up, the “excellent” or “good” group were defined as satisfactory efficacy.

2.6 Statistical analysis

The data were analyzed by SPSS (version 26.0) statistical software. The measurement data were expressed by mean ± standard deviation (X ± S), and the independent sample t-test was used to compare the two groups. The data that did not meet the normal distribution conditions were analyzed using Mann–Whitney Testing. P < 0.05 is statistically significant.

3 Results

Three of the 12 patients who received surgical treatment found high signal area on cervical MRI T2 image. 8 patients underwent anterior cervical decompression and fusion, 4 patients underwent posterior laminoplasty, and 3 patients refused surgical treatment. All 15 patients were followed up completely, with an average follow-up time of 8.2 months. All patients did not develop amyotrophy, and the muscle strength of 3 patients without surgery did not change significantly. There was no looseness or displacement of internal fixation during the follow-up period, as shown in Table 2.

Table 2
www.frontiersin.org

Table 2. Clinical data of 15 patients with CSA.

During postoperative follow-up, the muscle strength of 12 patients improved to different degrees compared with that before operation. The improvement effect was excellent in 2 cases, good in 6 cases, and moderate in 4 cases. There was no decrease in muscle strength after operation compared with that before operation. The satisfaction rate of the effect was 66.7% (8/12), as shown in Table 3. There was no statistical significance in preoperative muscle strength between the two groups (P = 0.310). The postoperative muscle strength of the proximal group was significantly better than that of the distal group, with a statistical difference (P = 0.041).

Table 3
www.frontiersin.org

Table 3. Postoperative muscle strength improvement in both groups.

Typical case: a 42-year-old male patient was admitted to the hospital with “left shoulder weakness for 20 years, aggravation and left shoulder amyotrophy for 6 years”. Physical examination: The gait was stable, and the physiological curvature of the cervical spine was straightened. The movement of the cervical spine was slightly limited, with no tenderness. The left deltoid muscle was obviously atrophic with muscle strength of grade 2, and the left shoulder joint was limited in abduction. See Figure 1 for imaging data. The electromyogram (EMG) showed that the anterior horn of the spinal cord had peripheral damage. It is diagnosed as proximal CSA. Anterior cervical decompression and fusion (C3/4, C4/5) were performed, and the left deltoid muscle strength recovered to level 4 at the follow-up of 10 months after the operation.

Figure 1
www.frontiersin.org

Figure 1. A 42-year-old male patient with proximal CSA underwent anterior cervical decompression and fusion (C3/4, C4/5). (A) The image before operation showed that the volume of the deltoid muscle in the left upper limb of the patient was significantly smaller than that of the right side, and the amyotrophy was obvious; (B) the lateral x-ray film of cervical vertebra showed that the curvature of cervical vertebra became straight before operation; (C) the x-ray film of the cervical spine in the extension position shows that the curvature of the cervical spine becomes straight; (D) x-ray film of cervical spine in anteflexion position before operation showed that the curvature of cervical spine was acceptable; (E) the sagittal MRI T2WI of the cervical spine showed compression of the spinal cord at C4/5 level and high signal in the spinal cord; (F) preoperative axial MRI showed that the left anterior horn of the spinal cord and the left nerve root were significantly compressed at C4/5 level, and the high signal changes of the bilateral anterior horn of the spinal cord, namely “snake eye sign”; (G) preoperative sagittal CT showed C4/5 vertebral osteophyte formation and uncinate joint hyperplasia; (H) three months after operation, the lateral x-ray film of cervical spine showed that the internal fixation position was good.

4 Discussion

CSA is relatively rare in clinical practice. Keegan first proposed this concept in 1965 (2). The majority of patients are middle-aged and elderly people, and the majority of patients are unilateral, with more males than females.

4.1 Pathogenesis of CSA

CSA is rare in clinic, and its pathogenesis is not very clear. According to domestic and foreign literature reports, CSA may have the following types: Selective ventral spinal cord nerve root (VNR) injury: Keegan et al. believe that anterior spinal root compression is one of the important mechanisms of the disease (2); Anterior horn (AH) cell injury of spinal cord: It is reported in the literature that there is symmetrical high signal in the AH area on the MRI T2 image of some patients with CSA, which is called “snake eye sign” (7); Anterior spinal artery (ASA) blood supply insufficiency: AH mainly receives the blood supply from the terminal branch of the anterior spinal artery. On the basis of cervical degeneration, cervical instability, and cervical spinal stenosis, cervical flexion and extension activities will cause compression or traction of blood vessels inside and outside the spinal cord, thus affecting the blood supply in the spinal cord (8). The blockage of ASA blood flow causes insufficient AH perfusion in multiple segments, which is considered to be one of the pathogenesis of CSA (9); Both VNR and AH are involved: Imajo believes that the herniated intervertebral disc or osteophyte at the posterior edge of the vertebral body can cause VNR and AH to be involved at the same time (10). Most of the patients in our research group conformed to the above view, and 5 patients had “snake eye sign” on imaging. In addition, the incidence rate of CSA is not significantly related to the degree of cervical degeneration (11).

4.2 Diagnosis and differential diagnosis

Diagnostic criteria: Patients with cervical spondylosis or previous history of cervical spondylosis, unilateral and a few bilateral upper limb amyotrophy, and the muscle strength of the affected limb has been weakened to a certain extent, without lower limb sensory disturbance; With or without upper limb root pain, sensory disturbance and positive pathological signs; Compression segment MRI T2WI weighted image with or without high signal of spinal cord; Neuroelectrophysiological examination was consistent with cervical spondylosis of amyotrophic type; Motor neuron disease, Hirayama disease and peripheral neuropathy (such as cubital tunnel syndrome) were excluded (12).

Motor neuron disease is the most critical disease to differentiate from CSA, and amyotrophic lateral sclerosis (ALS) is the most common one (13). The main clinical manifestations are progressive aggravation of skeletal muscle weakness, atrophy, muscle bundle fibrillation, bulbar paralysis and pyramidal bundle sign, which are common in the elderly. Neuroelectrophysiological examination is very important in the differential diagnosis of the two. Repetitive nerve stimulation is mainly used to evaluate the electrophysiological test of neuromuscular junction function, which has more obvious changes in the detection of ALS patients (14). EMG can identify the cause of muscular atrophy and determine the part and degree of nerve damage. The involvement of sternocleidomastoid muscle (accessory nerve innervation) on EMG is the most important identification point between CSA and ALS (15). If it is difficult to distinguish motor neuron disease from CSA, surgery should not be performed, because surgery may aggravate the condition of motor neuron disease.

Hirayama disease, also known as atrophy of the distal part of the upper limb in young people, occurs in adolescence and is mainly male. Its clinical features include major unilateral muscle weakness and atrophy of the hand and forearm. The onset of the disease is concealed, the progress is slow, and it often recovers within a few years. Cervical magnetic resonance imaging and neuroelectrophysiological examination are helpful to differentiate Hirayama disease from CSA, and the age of onset is also one of the differences between the two (16). In addition, CSA should be differentiated from cubital tunnel syndrome and rotator cuff disease (3).

4.3 Treatment

At present, there is no gold standard for the treatment of CSA. Conservative treatment is the early intervention for CSA by most clinicians, especially in the early stage of the disease, including traction, neck support fixation, hyperbaric oxygen, and taking vitamin B12 or vitamin E has also proved effective for some patients (17). Therefore, most clinicians suggest that conservative treatment should be taken as the initial treatment of CSA, especially those with the following related factors: age < 50 years old, duration of symptoms < 6 months, single-segment spinal canal stenosis, intervertebral foramen stenosis and patients who are effective for traction treatment (18).

Moreover, there is no consensus on the timing and mode of CSA surgery. Most scholars believe that once CSA is confirmed, surgical treatment can at least prevent the further development of the disease, even if it cannot effectively improve the symptoms of patients. Tauchi suggested that surgical treatment should be considered if the effect of conservative treatment is not good after 4 months of CSA symptoms. The decrease of the amplitude of the action potential of the compound muscle of the deltoid and biceps to 30%–50% of the contralateral side is also considered as the indication of surgical treatment (19).

There is no unified understanding of the choice of surgical methods. Both anterior cervical decompression and fusion and simple posterior laminoplasty have been reported in CSA (20). Uchida K believes that anterior cervical decompression and fusion is effective for most patients with CSA (6). Inui believes that posterior treatment is recommended when the segment is more than 2 with spinal canal stenosis (7).

In this study, there was no significant improvement in the symptoms of 3 patients with conservative treatment during the follow-up. The muscle strength of 12 patients was improved compared with that before operation, of which 2 cases were excellent, 6 cases were good, and 4 cases were moderate. The satisfactory rate of curative effect was 66.7% (8/12), there were 5 cases of proximal type and 3 cases of distal type. Our treatment group agreed that surgical treatment had a certain effect on patients with CSA. It is suggested that the surgical treatment of proximal CSA should be more active than that of distal CSA. Of the 12 patients in this study, 8 were treated with ACDF and 4 with LP. Most of the patients' condition improved compared with that before surgery. From the perspective of pathogenic factors, spinal cord or nerve compression is the main pathogenesis, and the main goal of surgery should be decompression (21).

Our study is a retrospective study with a short follow-up time and a small sample size, which requires a large sample of multi-center prospective further research. To sum up, the surgical effect of proximal CSA is significantly better than that of distal CSA. The proximal CSA with severe compression should be actively treated with surgery. The recovery effect of amyotrophy after distal CSA is poor. Whether to choose surgical treatment remains to be explored by spine orthopedic doctors all over the world.

5 Conclusions

The surgical effect of CSA of the proximal type is significantly better than that of the distal type. The recovery effect of amyotrophy after surgery for CSA of distal type is poor; thus, surgical treatment should be carefully considered.

Data availability statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.

Ethics statement

The studies involving humans were approved by Institutional Review Board standards at the First Affiliated Hospital of Zhengzhou University. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

ZY: Conceptualization, Data curation, Formal Analysis, Methodology, Resources, Writing – original draft. HZ: Conceptualization, Investigation, Resources, Software, Visualization, Writing – original draft. YW: Supervision, Writing – review & editing.

Funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Jiang SD, Jiang LS, Dai LY. Cervical spondylotic amyotrophy. Eur Spine J. (2011) 20:351–7. doi: 10.1007/s00586-010-1544-1

PubMed Abstract | Crossref Full Text | Google Scholar

2. Keegan JJ. The cause of dissociated motor loss in the upper extremity with cervical spondylosis. J Neurosurg. (1965) 23:528–36. doi: 10.3171/jns.1965.23.5.0528

PubMed Abstract | Crossref Full Text | Google Scholar

3. Baxter C, Miller TA, Ross DC, Doherty C. Treatment of cervical spondylotic amyotrophy with nerve transfers. J Hand Surg Am. (2018) 43:684.e1–e4. doi: 10.1016/j.jhsa.2017.12.020

PubMed Abstract | Crossref Full Text | Google Scholar

4. Inui Y, Miyamoto H, Sumi M, Uno K. Clinical outcomes and predictive factors relating to prognosis of conservative and surgical treatments for cervical spondylotic amyotrophy. Spine. (2011) 36:794–9. doi: 10.1097/BRS.0b013e3181e531a1

PubMed Abstract | Crossref Full Text | Google Scholar

5. Tauchi R, Imagama S, Inoh H, Yukawa Y, Kanemura T, Sato K, et al. Characteristics and surgical results of the distal type of cervical spondylotic amyotrophy. J Neurosurg Spine. (2014) 21:411–6. doi: 10.3171/2014.4.SPINE13681

PubMed Abstract | Crossref Full Text | Google Scholar

6. Uchida K, Nakajima H, Yayama T, Sato R, Kobayashi S, Kokubo Y, et al. Anterior and posterior decompressive surgery for progressive amyotrophy associated with cervical spondylosis: a retrospective study of 51 patients. J Neurosurg Spine. (2009) 11:330–7. doi: 10.3171/2009.3.SPINE08635

PubMed Abstract | Crossref Full Text | Google Scholar

7. Kameyama T, Ando T, Yanagi T, Yasui K, Sobue G. Cervical spondylotic amyotrophy. Magnetic resonance imaging demonstration of intrinsic cord pathology. Spine. (1998) 23:448–52. doi: 10.1097/00007632-199802150-00008

PubMed Abstract | Crossref Full Text | Google Scholar

8. Boekestein WA, Schelhaas HJ, van Putten MJ, Stegeman DF, Zwarts MJ, van Dijk JP. Motor unit number index (MUNIX) versus motor unit number estimation (MUNE): a direct comparison in a longitudinal study of ALS patients. Clin Neurophysiol. (2012) 123:1644–9. doi: 10.1016/j.clinph.2012.01.004

PubMed Abstract | Crossref Full Text | Google Scholar

9. Gilles FH, Nag D. Vulnerability of human spinal cord in transient cardiac arrest. Neurology. (1971) 21:833–9. doi: 10.1212/WNL.21.8.833

PubMed Abstract | Crossref Full Text | Google Scholar

10. Imajo Y, Kato Y, Kanchiku T, Suzuki H, Taguchi T. Pathology and prognosis of proximal-type cervical spondylotic amyotrophy: new assessment using compound muscle action potentials of deltoid and biceps brachii muscles. Spine. (2011) 36:E476–81. doi: 10.1097/BRS.0b013e3181e08d93

PubMed Abstract | Crossref Full Text | Google Scholar

11. Feng S, Fan Z, Yang Y, Fei Q, Li X. Atypical proximal cervical spondylotic amyotrophy: case report demonstrating clinical/imaging discrepancy. Int J Gen Med. (2020) 13:1367–72. doi: 10.2147/IJGM.S288588

PubMed Abstract | Crossref Full Text | Google Scholar

12. Fustes OH, Kay CSK, Lorenzoni PJ, Ducci RD, Werneck LC, Scola RH. Somatosensory evoked potentials in hirayama disease: a Brazilian study. Surg Neurol Int. (2020) 11:464. doi: 10.25259/SNI_861_2020

PubMed Abstract | Crossref Full Text | Google Scholar

13. Wu B, Yi X, Cui W, Rong T, Sang D, Xiao B, et al. An unrecognized ligament and its ossification in the craniocervical junction: prevalence, patient characteristics, and anatomic evidence. Clin Orthop Relat Res. (2021) 479:1816–26. doi: 10.1097/CORR.0000000000001719

PubMed Abstract | Crossref Full Text | Google Scholar

14. Zheng C, Jin X, Zhu Y, Lu F, Jiang J, Xia X. Repetitive nerve stimulation as a diagnostic aid for distinguishing cervical spondylotic amyotrophy from amyotrophic lateral sclerosis. Eur Spine J. (2017) 26:1929–36. doi: 10.1007/s00586-017-5060-4

PubMed Abstract | Crossref Full Text | Google Scholar

15. Shefner JM, Watson ML, Simionescu L, Caress JB, Burns TM, Maragakis NJ, et al. Multipoint incremental motor unit number estimation as an outcome measure in ALS. Neurology. (2011) 77:235–41. doi: 10.1212/WNL.0b013e318225aabf

PubMed Abstract | Crossref Full Text | Google Scholar

16. Hamada Y, Kanbayashi T, Takahashi K, Kamiya H, Kobayashi S, Sonoo M. Weak shoulder and arm sparing signs in amyotrophic lateral sclerosis. Muscle Nerve. (2022) 65:311–6. doi: 10.1002/mus.27480

PubMed Abstract | Crossref Full Text | Google Scholar

17. Luo W, Li Y, Xu Q, Gu R, Zhao J. Cervical spondylotic amyotrophy: a systematic review. Eur Spine J. (2019) 28:2293–301. doi: 10.1007/s00586-019-05990-7

PubMed Abstract | Crossref Full Text | Google Scholar

18. Tauchi R, Imagama S, Inoh H, Yukawa Y, Kanemura T, Sato K, et al. Appropriate timing of surgical intervention for the proximal type of cervical spondylotic amyotrophy. Eur J Orthop Surg Traumatol. (2015) 25(1):S107–13. doi: 10.1007/s00590-014-1504-2

PubMed Abstract | Crossref Full Text | Google Scholar

19. Zheng C, Song J, Zhu Y, Li X, Zhu D, Lyu F, et al. Motor unit number index (MUNIX) in the quantitative assessment of severity and surgical outcome in cervical spondylotic amyotrophy. Clin Neurophysiol. (2019) 130:1465–73. doi: 10.1016/j.clinph.2019.05.023

PubMed Abstract | Crossref Full Text | Google Scholar

20. Fujiwara Y, Tanaka N, Fujimoto Y, Nakanishi K, Kamei N, Ochi M. Surgical outcome of posterior decompression for cervical spondylosis with unilateral upper extremity amyotrophy. Spine. (2006) 31:E728–32. doi: 10.1097/01.brs.0000240207.00747.82

PubMed Abstract | Crossref Full Text | Google Scholar

21. Nandedkar SD, Barkhaus PE, Stalberg EV. Motor unit number index (MUNIX): principle, method, and findings in healthy subjects and in patients with motor neuron disease. Muscle Nerve. (2010) 42:798–807. doi: 10.1002/mus.21824

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: amyotrophy, cervical spondylotic, cervical vertebra, spinal disease, surgery

Citation: Yu Z, Zhang H and Wang Y (2024) Analysis of surgical treatment of cervical spondylotic amyotrophy. Front. Surg. 11:1409283. doi: 10.3389/fsurg.2024.1409283

Received: 29 March 2024; Accepted: 29 May 2024;
Published: 13 June 2024.

Edited by:

Sidong Yang, Hebei International Joint Research Centre for Spinal Diseases, China

Reviewed by:

Farid Amirouche, University of Illinois Chicago, United States
Xiaoming Guan, Shanxi Medical University, China

© 2024 Yu, Zhang and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yanjun Wang, wangyanjun0215@126.com

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.